Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy
NCT05197504
·
clinicaltrials.gov ↗
COMPLETED
Status
166
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
DRUG:
atezolizumab plus bevacizumab
Sponsor
CHA University